当前位置: 首页 >> 检索结果
共有 5002 条符合本次的查询结果, 用时 4.8209152 秒

4461. Institutionalizing Misinformation - The Dietary Supplement Listing Act of 2022.

作者: Pieter A Cohen.;Jerry Avorn.;Aaron S Kesselheim.
来源: N Engl J Med. 2022年387卷1期3-5页

4462. Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis.

作者: Luca Richeldi.;Arata Azuma.;Vincent Cottin.;Christian Hesslinger.;Susanne Stowasser.;Claudia Valenzuela.;Marlies S Wijsenbeek.;Donald F Zoz.;Florian Voss.;Toby M Maher.; .
来源: N Engl J Med. 2022年386卷23期2178-2187页
Phosphodiesterase 4 (PDE4) inhibition is associated with antiinflammatory and antifibrotic effects that may be beneficial in patients with idiopathic pulmonary fibrosis.

4463. Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.

作者: Alberto Papi.;Bradley E Chipps.;Richard Beasley.;Reynold A Panettieri.;Elliot Israel.;Mark Cooper.;Lynn Dunsire.;Allison Jeynes-Ellis.;Eva Johnsson.;Robert Rees.;Christy Cappelletti.;Frank C Albers.
来源: N Engl J Med. 2022年386卷22期2071-2083页
As asthma symptoms worsen, patients typically rely on short-acting β2-agonist (SABA) rescue therapy, but SABAs do not address worsening inflammation, which leaves patients at risk for severe asthma exacerbations. The use of a fixed-dose combination of albuterol and budesonide, as compared with albuterol alone, as rescue medication might reduce the risk of severe asthma exacerbation.

4464. Long-Term Care in the United States - Problems and Solutions.

作者: Susan L Mitchell.;Shawn Bloom.;David Gifford.;David Grabowski.;Jasmine Travers.
来源: N Engl J Med. 2022年386卷20期e54页

4465. Only Halfway There with Sudden Infant Death Syndrome.

作者: Richard D Goldstein.;Hannah C Kinney.;Alan E Guttmacher.
来源: N Engl J Med. 2022年386卷20期1873-1875页

4466. Reforming Nursing Home Financing, Payment, and Oversight.

作者: Rachel M Werner.;R Tamara Konetzka.;David C Grabowski.;David G Stevenson.
来源: N Engl J Med. 2022年386卷20期1869-1871页

4467. Syphilitic Aortitis.

作者: Shelly A Miller.;Elena R Ladich.
来源: N Engl J Med. 2022年386卷20期e55页

4468. Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.

来源: N Engl J Med. 2022年386卷19期1868页

4469. Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media.

来源: N Engl J Med. 2022年386卷19期1868页

4470. Medical Conditions and High-Altitude Travel. Reply.

作者: Andrew M Luks.;Peter H Hackett.
来源: N Engl J Med. 2022年386卷19期1866-1867页

4471. Medical Conditions and High-Altitude Travel.

作者: Rachelle Nuss.
来源: N Engl J Med. 2022年386卷19期1866页

4472. Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery. Reply.

作者: William F Fearon.;Frederik M Zimmermann.;Nico H J Pijls.
来源: N Engl J Med. 2022年386卷19期1865-1866页

4473. Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.

作者: Marco Ferlini.;Andrea Munafò.;L Oltrona Visconti.
来源: N Engl J Med. 2022年386卷19期1865页

4474. Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.

作者: Daniel Feldman.;Johny Nicolas.;George Dangas.
来源: N Engl J Med. 2022年386卷19期1864-1865页

4475. Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.

作者: Adam L Rosenblum.;Quinn R Pack.
来源: N Engl J Med. 2022年386卷19期1864页

4476. Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.

作者: Eric Van Belle.;Manesh Patel.;Justin Davies.
来源: N Engl J Med. 2022年386卷19期1863-1864页

4477. Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. Reply.

作者: James S Gammie.;Judy Hung.;Gorav Ailawadi.
来源: N Engl J Med. 2022年386卷19期1862-1863页

4478. Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.

作者: Anton Tomšič.;Meindert Palmen.;Robert J M Klautz.
来源: N Engl J Med. 2022年386卷19期1862页

4479. Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.

作者: Rajeev Gupta.;Fady Gerges.;Neelesh Gupta.
来源: N Engl J Med. 2022年386卷19期1861-1862页

4480. Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.

作者: Lavanya Bellumkonda.
来源: N Engl J Med. 2022年386卷19期1861页
共有 5002 条符合本次的查询结果, 用时 4.8209152 秒